Dow Jones-With a small plus, the Swiss stock market ended the trade on Tuesday. Encourable US consumer price data and a subsequent positive opening on Wall Street hardly supported. The extension of the customs break for Chinese products by the United States did not give the market a tailwind, because an agreement between the USA and Switzerland is still pending. A penalty of 39 percent has been charged on imports from Switzerland since August 7.
The SMI won 0.1 percent to 11,886 points. In the 21 SMI values, 15 price winners and six losers faced each other. 14.87 (previously: 17.05) million shares were implemented.
The SMI was slowed down by the heavyweight Nestle (-0.6%). Roche recovered from temporary losses and concluded. Novartis, who had been borne up the previous day by a positive medication study, increased by another 0.2 percent.
Swiss Re (-1.2%) fell in the pull from Hanover. The business figure of the German reinsurer had been admitted with disappointment.
In the second row, Tecan improved by 9.6 percent after the number template. The laboratory supplier had confirmed his annual goals and announced a share buyback. Observers described the order situation as encouraging.
On the other hand, Komax’s numbers were recorded with disappointment. The share dropped by 11.2 percent. The analysts of Vontobel noted that Komax was creating the low demand from the automotive industry and described the view as very weak. In her opinion, the company could have reached the sole of the valley.
Contact with the author: [email protected]
DJG/DJN/CLN/BRB
(More to follow) Dow Jones Newswires
August 12, 2025 11:45 ET (15:45 GMT)
Selected leverage products on Komax
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Komax
The lever must be between 2 and 20
Advertising